Cited by 126Lung Cancer Diagnosis and TreatmentHealth disparities and outcomesGlobal Cancer Incidence and Screening

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer

Open access

Hardy, Dale, Liu, Chih‐Chin, Xia, Rui, Cormier, Janice N., Chan, Wenyaw, White, Arica, Burau, Keith, Du, Xianglin L.·2009·Cancer

DOI 10.1002/cncr.24248

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: This study investigated whether there was a significant gap in receipt of treatment for nonsmall cell lung cancer (NSCLC) between blacks and whites, and whether the gap or disparity changed during the past 12 years from 1991 to 2002. METHODS: The study population consisted of 83,101 patients including 75,141 (90.4%) whites and 7960 (9.6%) blacks aged ≥65 years who were diagnosed with American Joint Committee on Cancer (AJCC) stages I‐IV NSCLC identified from the Surveillance, Epidemiology, and End Results (SEER) program's Medicare database. Age‐adjusted and sex‐adjusted rates and crude and adjusted odds ratios for receiving appropriate stage‐specific treatment of NSCLC were reported. RESULTS: For stages I‐II NSCLC combined, blacks were 37% less likely (OR, 0.63; 95% confidence interval [CI], 0.55‐0.73) to receive surgery, 42% less likely (OR, 0.58; 95% CI, 0.36‐0.92) to receive chemotherapy, and for stages III‐IV combined, 57% less likely (OR, 0.43; 95% CI, 0.30‐0.61) to receive chemotherapy compared with whites. Older patients, women, and those in lower socioeconomic quartiles had greater disparities in receipt of treatment compared with the highest income quartile. Disparity trends were not significantly narrowed during the past 12 years between blacks and whites for receipt of the above treatments. CONCLUSIONS: There have been substantial disparities in receiving recommended treatments between blacks and whites, and these disparities have been relatively stable without a significant trend of narrowing during the past 12 years. Efforts should focus on providing appropriate quality treatment and educating blacks on the value of having these treatments to reduce these disparities in receipt of treatment for NSCLC. Cancer 2009. © 2009 American Cancer Society.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/cncr.24248

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
International Statistical Classification of Diseases and Related Health Problems
(2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,182
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J. H., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,504
Development of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,846
Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives
Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717
Racial Differences in the Treatment of Early-Stage Lung Cancer
Bach, P. B., Cramer, L. D., Warren, J. L., & Begg, C. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411606 · Cited by 995
Non-Small Cell Lung Cancer
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37753-9.50111-0 · Cited by 859
Utility of the SEER-Medicare Data to Identify Chemotherapy Use
Warren, J. L., Harlan, L. C., Fahey, A., Virnig, B. A., Freeman, J. L., Klabunde, C. N., Cooper, G. S., & Knopf, K. (2002) · Medical Care · doi:10.1097/00005650-200208001-00008 · Cited by 404
β-catenin mutation and overexpression in hepatocellular carcinoma
Wong, C., Fan, S. T., & Ng, I. O. (2001) · Cancer · doi:10.1002/1097-0142(20010701)92:1 · Cited by 353

Show all 32 references

Research works printed but not linked: 4

American Cancer Society, 2007, Cancer facts and figures for African Americans 2007‐2008
American Cancer Society, 2008, Cancer statistics 2008
SEER program: Overview, 2008, Surveillance Research program
National Cancer Institute. The SEER program code manual. rev. ed, 1994, Cancer Statistic Branch, National Cancer Institute, National Institute of Health

Sorted by citations

Lung Cancer 2020
Bade, B. C., & Cruz, C. S. D. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.10.001 · Cited by 2,023
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Masters, G. A., Temin, S., Azzoli, C. G., Giaccone, G., Baker, S., Brahmer, J. R., Ellis, P. M., Gajra, A., Rackear, N., Schiller, J. H., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.1342 · Cited by 850
Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities
Desantis, C. E., Siegel, R. L., Sauer, A. G., Miller, K. D., Fedewa, S. A., Alcaraz, K. I., & Jemal, A. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21340 · Cited by 789
Cancer statistics for African American/Black People 2022
Giaquinto, A. N., Miller, K. D., Tossas, K. Y., Winn, R. A., Jemal, A., & Siegel, R. L. (2022) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21718 · Cited by 591
Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades
Lu, T., Yang, X., Huang, Y., Zhao, M., Li, M., Ma, K., Yin, J., Zhan, C., & Wang, Q. (2019) · Cancer Management and Research · doi:10.2147/cmar.s187317 · Cited by 565
Cancer statistics for African Americans, 2013
Desantis, C. E., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21173 · Cited by 291
Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis
Forrest, L. F., Adams, J., Wareham, H., Rubin, G., & White, M. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001376 · Cited by 220
Understanding Racial Disparities in Cancer Treatment and Outcomes
Morris, A. M., Rhoads, K. F., Stain, S. C., & Birkmeyer, J. D. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2010.02.051 · Cited by 210
Cancer Genes in Lung Cancer: Racial Disparities: Are There Any?
El-Telbany, A., & Ma, P. C. (2012) · Genes & Cancer · doi:10.1177/1947601912465177 · Cited by 156
Disparities in Access to Deep Brain Stimulation Surgery for Parkinson Disease
Chan, A. K.-H., McGovern, R. A., Brown, L. T., Sheehy, J. P., Zacharia, B. E., Mikell, C. B., Bruce, S. S., Ford, B., & McKhann, G. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5798 · Cited by 149
Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival
Soneji, S. S., Tanner, N. T., Silvestri, G. A., Lathan, C. S., & Black, W. C. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.03.059 · Cited by 137
Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review
Sosa, E., D’Souza-Rushton, G. C., Akhtar, A., Sur, M., Love, K., Duffels, J., Raz, D. J., Kim, J. Y., Sun, V. C.-Y., & Erhunmwunsee, L. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21671 · Cited by 137
Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer
Schabath, M. B., Cress, W. D., & Muñoz-Antonia, T. (2016) · Cancer Control · doi:10.1177/107327481602300405 · Cited by 127
Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States
Blom, E. F., ten Haaf, K., Arenberg, D. A., & de Koning, H. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201901-094oc · Cited by 115
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer
Socinski, M. A., Langer, C. J., Okamoto, I., Hon, J. K., Hirsh, V., Dakhil, S. R., Page, R. D., Orsini, J., Zhang, H., & Renschler, M. F. (2013) · Annals of Oncology · doi:10.1093/annonc/mds461 · Cited by 108
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Hanna, N. H., Johnson, D. H., Temin, S., & Masters, G. A. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.026716 · Cited by 105
Cultural Factors Associated with Racial Disparities in Lung Cancer Care
Lin, J. J., Mhango, G., Wall, M. M., Lurslurchachai, L., Bond, K. T., Nelson, J. E., Berman, A., Salazar‐Schicchi, J., Powell, C. A., Keller, S. M., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201402-055oc · Cited by 95
Sublobar Resection for Clinical Stage IA Non–small-cell Lung Cancer in the United States
Speicher, P. J., Gu, L., Gulack, B. C., Wang, X., D’Amico, T. A., Hartwig, M. G., & Berry, M. F. (2015) · Clinical Lung Cancer · doi:10.1016/j.cllc.2015.07.005 · Cited by 93
Opportunities to address lung cancer disparities among African Americans
Coughlin, S. S., Matthews-Juarez, P., Juárez, P. D., Melton-Fant, C. E., & King, M. (2014) · Cancer Medicine · doi:10.1002/cam4.348 · Cited by 82
The Effects of Race and Ethnicity on Thyroid Cancer Incidence
Magreni, A., Bann, D. V., Schubart, J. R., & Goldenberg, D. (2015) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2014.3740 · Cited by 80
Racial and regional disparities in lung cancer incidence
Underwood, J. M., Townsend, J. S., Tai, E. W., Davis, S. P., Stewart, S. L., White, A. L., Momin, B. R., & Fairley, T. L. (2011) · Cancer · doi:10.1002/cncr.26479 · Cited by 78
Self-citation
Factors Influencing Emergency Department Preference for Access to Healthcare
Brown, L. E., Burton, R. C., Hixon, B., Kakade, M. S., Bhagalia, P., Vick, C. C., Edwards, A., & Hawn, M. T. (2011) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2011.11.6820 · Cited by 77
What Happens to Racial and Ethnic Minorities after Cancer Surgery at American College of Surgeons National Surgical Quality Improvement Program Hospitals?
Parsons, H. M., Habermann, E. B., Stain, S. C., Vickers, S. M., & Al‐Refaie, W. B. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2011.12.024 · Cited by 71
Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer
Williams, C. D., Salama, J. K., Moghanaki, D. M., Karas, T. Z., & Kelley, M. J. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.030 · Cited by 69
Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study
Mehta, R. S., Lenzner, D. E., & Argiris, A. E. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2087-3 · Cited by 68
Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States
Verma, V., Haque, W. M., Cushman, T. R., Lin, C. H., Simone, C. B., Chang, J. Y., McClelland, S., & Welsh, J. W. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000253 · Cited by 66
Racial and Ethnic Differences in Beliefs About Lung Cancer Care
Jonnalagadda, S., Lin, J. J., Nelson, J. E., Powell, C. A., Salazar‐Schicchi, J., Berman, A., Keller, S. M., Smith, C. B., Lurslurchachai, L., Halm, E. A., et al. (2012) · CHEST Journal · doi:10.1378/chest.12-0330 · Cited by 62
The Effects of Time to Treatment Initiation for Patients With Non–small-cell Lung Cancer in the United States
Cushman, T. R., Jones, B. L., Akhavan, D., Rusthoven, C. G., Verma, V., Salgia, R., Sedrak, M. S., Massarelli, E., Welsh, J. W., & Amini, A. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.09.004 · Cited by 61
Effect of Insurance Status on the Surgical Treatment of Early-Stage Non-Small Cell Lung Cancer
Groth, S. S., Al‐Refaie, W. B., Zhong, W., Vickers, S. M., Maddaus, M. A., D’Cunha, J., & Habermann, E. B. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.10.079 · Cited by 58
Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial
Balekian, A. A., Wisnivesky, J. P., & Gould, M. K. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.011 · Cited by 58
Racial Diversity of Actionable Mutations in Non–Small Cell Lung Cancer
Bollig-Fischer, A. B., Chen, W., Gadgeel, S. M., Wenzlaff, A. S., Coté, M. L., Schwartz, A. G., & Bepler, G. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000420 · Cited by 56
Lung Cancer Survival among Black and White Patients in an Equal Access Health System
Li, Z., Enewold, L., Zahm, S. H., Shriver, C. D., Zhou, J., Marrogi, A. J., McGlynn, K. A., & Zhu, K. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0560 · Cited by 54
Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry
Jones, C. C., Mercaldo, S., Blume, J. D., Wenzlaff, A. S., Schwartz, A. G., Chen, H., Deppen, S. A., Bush, W. S., Crawford, D. C., Chanock, S. J., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.05.032 · Cited by 54
Socioeconomic Disparities in Lung Cancer Treatment and Outcomes Persist Within a Single Academic Medical Center
Yorio, J. T., Yan, J., Xie, Y., & Gerber, D. E. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.03.002 · Cited by 47
Drug-sensitiveFGFR3 mutations in lung adenocarcinoma
Chandrani, P., Prabhash, K., Prasad, R., Sethunath, V., Ranjan, M., Iyer, P. S., Aich, J., Dhamne, H., Iyer, D. N., Upadhyay, P., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw636 · Cited by 46
Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non–Small Cell Lung Cancer Patients
Palazzo, L. L., Sheehan, D. F., Tramontano, A. C., & Kong, C. Y. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0917 · Cited by 45
Genomic landscape of lung adenocarcinomas in different races
Shi, H., Seegobin, K., Heng, F., Zhou, K., Chen, R., Qin, H., Manochakian, R., Zhao, Y., & Lou, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.946625 · Cited by 45
Influence of Comorbidity on Racial Differences in Receipt of Surgery Among US Veterans With Early-Stage Non–Small-Cell Lung Cancer
Williams, C. D., Stechuchak, K. M., Zullig, L. L., Provenzale, D., & Kelley, M. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.1170 · Cited by 43
Association Between Race and Survival of Patients With Non–Small-Cell Lung Cancer in the United States Veterans Affairs Population
Ganti, A. K., Subbiah, S. P., Kessinger, A., Gonsalves, W. I., Silberstein, P. T., & Loberiza, F. R. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.11.004 · Cited by 41
The Impact of Residential Racial Segregation on Non-Small Cell Lung Cancer Treatment and Outcomes
Annesi, C. A., Poulson, M. R., Mak, K. S., Tapan, Ü., Dechert, T. A., Litle, V. R., & Suzuki, K. (2021) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2021.04.096 · Cited by 41
Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer
Berry, M. F., Worni, M., Pietrobon, R. S., D’Amico, T. A., & Akushevich, I. V. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828916aa · Cited by 39
Urban/Rural Patterns in Receipt of Treatment for Non–Small Cell Lung Cancer Among Black and White Medicare Beneficiaries, 2000-2003
Steele, C. B., Pisu, M., & Richardson, L. C. (2011) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30410-7 · Cited by 39
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis
Koshy, M., Malik, R., Spiotto, M. T., Mahmood, U. X., Weichselbaum, R. R., & Sher, D. J. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000418 · Cited by 37
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non–Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis
Ahmed, H. Z., Liu, Y., O’Connell, K., Ahmed, M. Z., Cassidy, R. J., Gillespie, T. W., Patel, P. R., Pillai, R. N., Behera, M., Steuer, C. E., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.04.009 · Cited by 37
Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century
Dalwadi, S. M., Lewis, G. D., Bernicker, E., Butler, E. B., Teh, B. S., & FARACH, A. M. (2018) · Clinical Lung Cancer · doi:10.1016/j.cllc.2018.11.004 · Cited by 36
Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of Life
Riaz, F., Gan, G., Li, F., Davidoff, A. J., Adelson, K. B., Presley, C. J., Adamson, B. J. S., Shaw, P., Parikh, R. B., Mamtani, R., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00010 · Cited by 36
Race by Sex Differences in Depression Symptoms and Psychosocial Service Use Among Non-Hispanic Black and White Patients With Lung Cancer
Traeger, L., Cannon, S., Keating, N. L., Pirl, W. F., Lathan, C., Martin, M. Y., He, Y., & Park, E. R. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.6466 · Cited by 36
The Impact of Socioeconomic Status on Presentation and Treatment of Diverticular Disease
Csikesz, N. G., Singla, A., Simons, J. P., Tseng, J. F., & Shah, S. A. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-1031-3 · Cited by 36
Generalizability of Trial Results to Elderly Medicare Patients With Advanced Solid Tumors (Alliance 70802)
Lamont, E. B., Schilsky, R. L., He, Y., Muss, H. B., Cohen, H. J., Hurria, A., Meilleur, A., Kindler, H. L., Venook, A. P., Lilenbaum, R., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju336 · Cited by 33
Racial differences in the perception of lung cancer
Lathan, C. S., Okechukwu, C. A., Drake, B. F., & Bennett, G. G. (2010) · Cancer · doi:10.1002/cncr.24923 · Cited by 32
Race and Ethnicity in Cancer Therapy: What Have We Learned?
Grenade, C., Phelps, M. A., & Villalona-Calero, M. A. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.5 · Cited by 30
Sociodemographic disparities in the treatment of small renal masses
Becker, A., Roghmann, F., Trinh, Q., Hansen, J., Tian, Z., Shariat, S. F., Noldus, J., Perrotte, P., Graefen, M., Karakiewicz, P. I., et al. (2013) · British Journal of Urology · doi:10.1111/bju.12111 · Cited by 30
Black:White disparities in lung cancer mortality in the 50 largest cities in the United States
Hunt, B. R., & Balachandran, B. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.10.003 · Cited by 30
Cost and Utilization of Lung Cancer End-of-Life Care Among Racial-Ethnic Minority Groups in the United States
Chen, Y., Criss, S. D., Watson, T. R., Eckel, A. L., Palazzo, L. L., Tramontano, A. C., Wang, Y., Mercaldo, N. D., & Kong, C. Y. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0303 · Cited by 28
Effect of race on thyroid cancer care in an equal access healthcare system
Brown, S. R., Lee, S., Brown, T. A., & Waddell, B. E. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.01.020 · Cited by 26
Racial and socioeconomic disparities in the use of stereotactic body radiotherapy for treating non-small cell lung cancer: a narrative review
Lin, Y., & Mak, K. S. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-20-3199 · Cited by 23
“Cutting” on cancer: Attitudes about cancer spread and surgery among primary care patients in the USA
James, A. S., Daley, C. M., & Greiner, K. A. (2011) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.09.017 · Cited by 25
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes
Villaruz, L. C., & Socinski, M. A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.022 · Cited by 25
Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time-trend analysis of the National Cancer Data Base
Engelhardt, K. E., Feinglass, J. M., DeCamp, M. M., Bilimoria, K. Y., & Odell, D. D. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.03.174 · Cited by 25
Patient navigation for lung cancer screening in an urban safety-net system: Protocol for a pragmatic randomized clinical trial
Gerber, D. E., Hamann, H. A., Santini, N. O., Abbara, S., Chiu, H. T., McGuire, M. F., Quirk, L., Zhu, H., & Lee, S. J. C. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.003 · Cited by 24
Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members
Check, D. K., Albers, K. B., Uppal, K. M., Suga, J. M., Adams, A. S., Habel, L. A., Quesenberry, C. P., & Sakoda, L. C. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.09.006 · Cited by 24
Lung cancer early detection and health disparities: the intersection of epigenetics and ethnicity
Lerner, L., Winn, R. A., & Hulbert, A. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.07 · Cited by 23
Clinical Evidence on the Undertreatment of Older and Poor Performance Patients Who Have Advanced Non-Small-Cell Lung Cancer: Is There a Role for Targeted Therapy in These Cohorts?
Langer, C. J. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.02.001 · Cited by 22
The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients
Hoadley, A., Bass, S. B., Chertock, Y., Brajuha, J. A., D’Avanzo, P. A., Kelly, P. J. A., & Hall, M. J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19052598 · Cited by 22
Prevalence and Predictors of Neoadjuvant Therapy for Stage IIIA Non-Small Cell Lung Cancer in the National Cancer Database: Importance of Socioeconomic Status and Treating Institution
Sher, D. J., Liptay, M. J., & Fidler, M. J. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.01.033 · Cited by 21
Outcomes after treatment of 17 378 patients with locally advanced (T3N0–2) non-small-cell lung cancer†
Speicher, P. J., Englum, B. R., Ganapathi, A. M., Onaitis, M. W., D’Amico, T. A., & Berry, M. F. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu270 · Cited by 21
Non-small Cell Lung Cancer Treatment Receipt and Survival Among African-Americans and Whites in a Rural Area
Hua, X., Ward, K. C., Gillespie, T. W., Lipscomb, J., & Goodman, M. G. (2013) · Journal of Community Health · doi:10.1007/s10900-013-9813-7 · Cited by 21
Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations
Gerber, D. E., Lakoduk, A. M., Priddy, L. L., Yan, J., & Xie, X. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0083 · Cited by 22
Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010
Kaniski, F., Enewold, L., Thomas, A., Malik, S. M., Stevens, J. L., & Harlan, L. C. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.11.020 · Cited by 20
Assessing Barriers and Facilitators to Lung Cancer Screening: Initial Findings from a Patient Navigation Intervention
Lee, S. J. C., Lee, J. L., Zhu, H., Chen, P. M., Wahid, U., Hamann, H. A., Bhalla, S., Catalán, R., Natchimuthu, V. S., Johnson, D. H., et al. (2023) · Population Health Management · doi:10.1089/pop.2023.0053 · Cited by 20
Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites
Hamilton, B. K., Rybicki, L. A., Sekeres, M. A., Kalaycio, M. E., Hanna, R., Sobecks, R. M., Dean, R. M., Duong, H., Hill, B. T., Bolwell, B. J., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.44 · Cited by 20
Lung cancer care: the impact of facilities and area measures.
Lathan, C. S. (2015) · PubMed Central · doi:10.3978/j.issn.2218-6751.2015.07.23 · Cited by 20
White–Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival Among Older Adults
Krok‐Schoen, J. L., Fisher, J. L., Baltic, R. D., & Paskett, E. D. (2017) · Journal of Aging and Health · doi:10.1177/0898264317696777 · Cited by 20
Stereotactic radiotherapy of the prostate: fractionation and utilization in the United States
Weiner, J., Schwartz, D. A., Shao, M. S., Osborn, V. W., Choi, K. N., & Schreiber, D. P. (2017) · Radiation Oncology Journal · doi:10.3857/roj.2017.02026 · Cited by 20
Race, insurance type, and stage of presentation among lung cancer patients
Efird, J. T., Landrine, H., Shiue, K. Y., O’Neal, W. T., Podder, T. K., Rosenman, J. G., & Biswas, T. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-710 · Cited by 19
Prevalence And Impact of Medical Comorbidities in A Real‐World Lung Cancer Screening Population
Majeed, H., Zhu, H., Williams, S., Hamann, H. A., Natchimuthu, V. S., Lee, J. L., Santini, N. O., Browning, T. G., Prasad, T., Adesina, J. O., et al. (2022) · Clinical Lung Cancer · doi:10.1016/j.cllc.2022.03.009 · Cited by 18
Nonverbal synchrony as a behavioural marker of patient and physician race-related attitudes and a predictor of outcomes in oncology interactions: protocol for a secondary analysis of video-recorded cancer treatment discussions
Hamel, L. M., Moulder, R. G., Jr., Albrecht, T. L., Boker, S. M., Eggly, S. S., & Penner, L. A. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023648 · Cited by 19
Role of the Pulmonologist in Ordering Post-Procedure Molecular Markers in Non–Small-Cell Lung Cancer: Implications for Personalized Medicine
Murgu, S. D., & Colt, H. G. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.04.002 · Cited by 17
Survival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel
Langer, C. J., Hirsh, V., Okamoto, I., Lin, F.-J., Wan, Y., Whiting, S., Ong, T. J., Renschler, M. F., & Botteman, M. F. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.181 · Cited by 17
Effect of Race and Insurance on the Outcome of Stage I Non-small Cell Lung Cancer.
Biswas, T., Walker, P. R., Podder, T. K., & Efird, J. T. (2015) · PubMed · Cited by 16
Epidemiology of Lung Cancer
Metintaş, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-22483-6_57-1 · Cited by 16
Reasons for Lack of Referral to Medical Oncology for Systemic Therapy in Stage Iv Non-small-cell Lung Cancer: Comparison of 2003–2006 with 2010–2011
Ko, J. J., Tudor, R., Li, H., Liu, M.-F., Skolnik, K., Boland, W. K., Macklow, J., Morris, D. G., & Bebb, D. G. (2017) · Current Oncology · doi:10.3747/co.24.3691 · Cited by 16
Patterns of Care and Survival in Stage III NSCLC Among Black and Latino Patients Compared With White Patients
Vyfhuis, M. A. L., Bentzen, S. M., Molitoris, J. K., Diwanji, T. P., Badiyan, S. N., Grover, S., Adebamowo, C., Simone, C. B., & Mohindra, P. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.02.015 · Cited by 16
Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancer
Uprety, D., Seaton, R., Hadid, T. H., Mamdani, H. M., Sukari, A. W., Ruterbusch, J. J., & Schwartz, A. G. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae118 · Cited by 14
Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system
Zullig, L. L., Williams, C. D., & Fortune-Britt, A. G. (2015) · Cancer Management and Research · doi:10.2147/cmar.s75463 · Cited by 14
Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net Hospital
Burns, L., Jani, C., Radwan, A., Omari, O. A., Patel, M., Oxnard, G. R., & Tapan, Ü. (2022) · Clinical Lung Cancer · doi:10.1016/j.cllc.2022.11.002 · Cited by 13
Race and intensity of post-remission therapy in acute myeloid leukemia
Brady, A. K., Fu, A. Z., Earl, M. A., Kalaycio, M. E., Advani, A. S., Saunthararajah, Y., Sobecks, R. M., Copelan, E. A., & Sekeres, M. A. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.07.020 · Cited by 13
Utilization of the Veterans Affairs Central Cancer Registry to evaluate lung cancer outcomes
Klein, M. A., Scaria, G. S., & Ganti, A. K. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.10.001 · Cited by 11
Antecedents of Vaccine Hesitancy in WEIRD and East Asian Contexts
Courtney, D. S., & Bliuc, A. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.747721 · Cited by 11
Non-Small-Cell Lung Cancer Clinicopathologic Features and Survival Outcomes in Asian Pacific Islanders Residing in the United States: A SEER Analysis
Hamid, M. S., Shameem, R., Gafoor, K., George, J., Mina, B. A., & Sullivan, K. M. (2015) · Journal of Cancer Epidemiology · doi:10.1155/2015/269304 · Cited by 11
Depression and Undertreatment of Depression: Potential Risks and Outcomes in Black Patients with Lung Cancer
Traeger, L. N., Cannon, S., Pirl, W. F., & Park, E. R. (2013) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2012.761320 · Cited by 10
Relationship between Patient Income Level and Mitral Valve Repair Utilization
Vassileva, C. M., Boley, T. M., Standard, J., Markwell, S. J., & Hazelrigg, S. R. (2013) · The Heart Surgery Forum · doi:10.1532/hsf98.20121105 · Cited by 10
Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancer
Riaz, F., Presley, C. J., Chiang, A. C., Longtine, J. A., Soulos, P. R., Adelson, K. B., Herbst, R. S., Nussbaum, N. C., Sorg, R. A., Abernethy, A. P., et al. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.01.016 · Cited by 10
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer
Punekar, S. R., Griffin, M. M., Masri, L., Roman, S. D., Makarov, D. V., Sherman, S. E., & Becker, D. J. (2021) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000875 · Cited by 8
Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model
Copeland, J., Neal, E., Phillips, W., Hofferberth, S. C., Lathan, C. S., Donington, J. S., & Colson, Y. L. (2023) · MethodsX · doi:10.1016/j.mex.2023.102338 · Cited by 8
Factors leading to disparity in lung cancer diagnosis among black/African American communities in the USA: a qualitative study
Thuo, N. B., Martins, T., Manley, E., Standifer, M. K., Sultan, D. H., Faris, N. R., Hill, A. M., Thompson, M., Jeremiah, R. D., & Achkar, M. A. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073886 · Cited by 8
Racial-Sex Disparities—A Challenging Battle Against Cancer Mortality in the USA
Fu, W. J. (2014) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-014-0059-6 · Cited by 8
Clinical Characteristics and Presentation of Lung Cancer According to Race and Place of Birth
Said, R., Terjanian, T. O., & Taioli, E. (2010) · Future Oncology · doi:10.2217/fon.10.89 · Cited by 8
The Relation of Race and Type of Health Insurance to Long-Term Risk of Mortality Among Lung Cancer Patients in Rural Eastern North Carolina
ElChoufani, S. E., Efird, J. T., O’Neal, W. T., Davies, S. W., Landrine, H., & Biswas, T. (2013) · North Carolina Medical Journal · doi:10.18043/ncm.74.6.464 · Cited by 8
Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non–Small-Cell Lung Cancer
Reynolds, C. H., Patel, J. D., Garon, E. B., Olsen, M. R., Bonomi, P., Govindan, R., Pennella, E. J., Liu, J., Guba, S. C., Shi, L., et al. (2014) · Clinical Lung Cancer · doi:10.1016/j.cllc.2014.11.004 · Cited by 7

Authors: Hardy, D., Liu, C., Xia, R., Cormier, J. N., Chan, W., White, A., Burau, K., & Du, X. L.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
Corresponding author: Hardy, Dale
ORCID: Hardy, Dale
Xia, Rui
Cormier, Janice N.
Chan, Wenyaw
White, Arica
Du, Xianglin L.
Venue: Cancer
Publisher: Wiley
Published: 2009-04-28
Volume: 115
Issue: 10
Pages: 2199-2211
ISSN: 0008-543X (ISSN-L)
1097-0142
DOI: 10.1002/cncr.24248
OpenAlex: W2084671951
Cited by: 126
References: 32
Citations by year: 2025: 2 · 2024: 5 · 2023: 5 · 2022: 9 · 2021: 6 · 2020: 5 · 2019: 12 · 2018: 8 · 2017: 7 · 2016: 8 · 2015: 11 · 2014: 15 · 2013: 13 · 2012: 7
FWCI: 5.59
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: Agency for Healthcare Research and Quality (RO1-HS016743)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Social Sciences › Health › Health disparities and outcomes
Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords: racial disparities, non-small cell lung cancer, elderly patients, black-white disparities, treatment receipt, chemotherapy, socioeconomic status, Medicare beneficiaries, SEER, treatment trends
MeSH terms: Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Socioeconomic Factors, SEER Program, Black People, White People, Healthcare Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks